Changing Services, Changing Oncology Pharmacy COVID-19 Position Statement

During the COVID-19 pandemic, oncology pharmacy services have had to adapt quickly and innovatively to continue to provide care to cancer patients. This document outlines both the clinical and operational responses implemented by BOPA members during the initial phase of COVID-19.

For clinical services we summarise different examples of responses , the key role oncology pharmacy services play in this response and recommendations for continued oncology pharmacy involvement in the future.
For operational services we identify the benefits, opportunities, risks and challenges of the responses and further considerations for reviewing these responses.

The document also highlights some of the next steps oncology pharmacy services and the wider oncology service could take in planning for the future phase of the COVID-19 pandemic.

We hope BOPA members find this document useful as it shows how we in oncology pharmacy have a pivotal role in providing cancer care and that whatever the challenges of continuing to provide care in a post COVID-19 world, so long as we plan for the risks, take opportunities, prepare to adapt and share our learning as a community, we will be able to meet them.

To access the document you must be a free or paid member of BOPA.
https://www.bopa.org.uk/resources/changing-services-changing-oncology-pharmacy-covid-19-position-statement/ 

Latest News

By BOPA Committee on 22nd July 2024

REMINDER – 2024 Elections to the BOPA Executive Committee: Call for nomination of members

BOPA is looking for new Executive Committee members who are dedicated to furthering the association’s aims and who are willing, and able, to spend time helping run the organisation. Those…

Read article
By BOPA Committee on 12th July 2024

TRANScribing: Clinical considerations for safe and inclusive prescribing for transgender and non-binary patients

BOPA is delighted to announce the publication of TRANScribing: Clinical considerations for safe and inclusive prescribing for transgender and non-binary patients in collaboration with OUTpatients. It is estimated that one…

Read article
By BOPA Committee on 11th July 2024

Round Table Discussion at #BOPA2024

  As an exciting addition to the 2024 conference, we invite you all to participate in one of our interactive sessions on the Sunday morning. We have a lineup of…

Read article
By BOPA Committee on 10th July 2024

APTUK Position Statement for DHSC PGD Update

The Association of Pharmacy Technicians UK (APTUK), as the professional leadership body for pharmacy technicians, welcome the positive outcome of the DHSC consultation supporting the enabling of registered pharmacy technicians…

Read article